drug · small molecule
ALDACTONE
Marketedupdated 3mo agoby $PFE PFIZER INC🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6Small molecule drug with a maximum clinical stage of Approval (across all indications), with 12 approved and 25 investigational indications.
targets
Mineralocorticoid receptor
all catalysts(42)
approval · 42
Jan 21, 1960
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 10, 1976
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Mar 4, 1981
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jun 22, 1981
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jun 30, 1981
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
May 3, 1982
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Dec 30, 1982
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Apr 7, 1983
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jul 29, 1983
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 29, 1983
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 29, 1983
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Dec 20, 1983
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Mar 22, 1984
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 5, 1984
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Aug 15, 1985
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Sep 26, 1985
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jan 13, 1986
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jun 15, 1987
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 23, 1987
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 9, 1988
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Oct 30, 1989
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jan 23, 1990
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Mar 15, 1990
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
May 7, 1992
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
May 31, 1995
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
May 14, 1996
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jul 30, 1997
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jul 30, 1997
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jan 13, 1999
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Mar 26, 1999
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 26, 2002
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 25, 2008
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Sep 22, 2011
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Sep 17, 2012
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jun 12, 2013
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Oct 22, 2014
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
May 1, 2015
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Apr 11, 2016
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Mar 6, 2018
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Jul 28, 2020
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Dec 19, 2022
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Nov 14, 2025
approval
$PFE26.79-0.06%
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Trials studying ALDACTONE
- phase2Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
- phase2A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression
- phase3Bioavailability and Bioequivalence Study of Extended Release Torsemide and Spironolactone
- phase3A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
- phase3A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects
- phase3Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects
- phase4Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
- phase4Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that